A.D.A.M. Bioprinting
PrivateLast Round
Early Funding
Oct 1, 2022
Est. Valuation
$33M
Total Funding Raised
$1.63M
Company Overview
A.D.A.M. Bioprinting operates in Healthcare & Life Sciences and is based in Stamford, Connecticut. Its latest recorded funding round was a Series A round in April 2022.
A.D.A.M. Bioprinting is a medicine company that provides an on-demand personalized implant manufacturing infrastructure using 3D-bioprinting technology for bone implants.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, 3D Printing, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A.D.A.M. Bioprinting Comparables
Compare A.D.A.M. Bioprinting with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ossiform | 82% | |
| Xilloc Medical B.V. | 78% | |
| AIP Scientific | 77% |
For institutional investors. Book with your work email.
A.D.A.M. Bioprinting Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 1, 2022 | ||||
| Series A | Apr 21, 2022 | ||||
| Seed | Dec 1, 2018 |
For institutional investors. Book with your work email.
A.D.A.M. Bioprinting Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Ukraine Foundation | Grant |
| Ukrainian World Congress | Grant |
| WeFund Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 29, 2023
Grew 19% QoQ, from 16 to 19 employees.
- Oct 1, 2022
Raised $8M in early funding.
For institutional investors. Book with your work email.
A.D.A.M. Bioprinting Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about A.D.A.M. Bioprinting's valuation, stock price, and market status.
Is A.D.A.M. Bioprinting a public or private company?
A.D.A.M. Bioprinting is a private company.
What is the current stock price of A.D.A.M. Bioprinting?
A.D.A.M. Bioprinting is a private company, so its shares have no public market price. Caplight tracks A.D.A.M. Bioprinting's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is A.D.A.M. Bioprinting worth (valuation)?
A.D.A.M. Bioprinting's valuation is estimated at $33.0M based on funding round data.
Can I buy A.D.A.M. Bioprinting stock?
A.D.A.M. Bioprinting shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was A.D.A.M. Bioprinting's last funding round?
A.D.A.M. Bioprinting's most recent funding round was Early Funding on October 1, 2022.
Who are the main investors in A.D.A.M. Bioprinting?
Key investors in A.D.A.M. Bioprinting include Global Ukraine Foundation, Ukrainian World Congress, WeFund Ventures.
Will A.D.A.M. Bioprinting IPO soon?
No public IPO plans have been announced for A.D.A.M. Bioprinting.
How can I track A.D.A.M. Bioprinting secondary market activity?
Caplight tracks bids, offers, and trades in A.D.A.M. Bioprinting's shares on secondary markets.